BioClinica, Inc. Partners With TEDA Cardiovascular Hospital

Published: Jun 21, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 20, 2013 -- BioClinica®, a clinical trial services company headquartered in the US, has formed a strategic partnership with TEDA International Cardiovascular Hospital (TICH) in Tianjin, China, which will offer the company’s cardiac safety monitoring services in Asia. BioClinica recently completed the first CFDA-requested Thorough QT (TQT) cardiac safety study in China for a domestic China company at the hospital. BioClinica offers imaging core labs on two continents, along with worldwide eClinical and data management services. More details....

Help employers find you! Check out all the jobs and post your resume.

Back to news